TSINGOS CHRISTINE A
Insider transactions at 4 companies
This page shows all SEC Form 4 filings attributed to TSINGOS CHRISTINE A. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| NVST | Award / Grant | 10,450 | — | — | Jun 10, 2025 | |
| VREX | Option Exercise | 6,573 | — | — | Feb 13, 2025 | |
| ONTO | Award / Grant | 809 | — | — | May 22, 2024 | |
| NVST | Award / Grant | 10,085 | — | — | May 21, 2024 | |
| 0001850079 | Award / Grant | 46,752 | — | — | May 1, 2024 | |
| VREX | Option Exercise | 6,881 | — | — | Feb 11, 2024 | |
| NVST | Award / Grant | 5,425 | — | — | May 23, 2023 | |
| ONTO | Award / Grant | 2,200 | — | — | May 9, 2023 | |
| VREX | Option Exercise | 6,160 | — | — | Feb 13, 2023 | |
| 0001850079 | Award / Grant | 20,630 | — | — | Jun 9, 2022 | |
| NVST | Award / Grant | 4,435 | — | — | May 24, 2022 | |
| ONTO | Award / Grant | 2,100 | — | — | May 10, 2022 | |
| VREX | Option Exercise | 5,098 | — | — | Feb 14, 2022 | |
| NVST | Award / Grant | 4,020 | — | — | May 25, 2021 | |
| ONTO | Award / Grant | 2,500 | — | — | May 11, 2021 | |
| VREX | Option Exercise | 4,312 | — | — | Feb 11, 2021 | |
| ONTO | Award / Grant | 4,800 | — | — | May 12, 2020 | |
| VREX | Option Exercise | 5,148 | — | — | Feb 14, 2020 | |
| ONTO | Award / Grant | 4,041 | — | — | May 22, 2019 | |
| BIO-B | EVP and CFO | Sale | 1,411 | $248.00 | $349,928 | Dec 14, 2018 |
| BIO-B | EVP and CFO | Option Exercise | 660 | — | — | Sep 11, 2018 |
| BIO-B | EVP and CFO | Option Exercise | 400 | — | — | Sep 10, 2018 |
| BIO-B | EVP and CFO | Option Exercise | 500 | — | — | Sep 7, 2018 |
| BIO-B | EVP and CFO | Option Exercise | 600 | — | — | Sep 5, 2018 |
| ONTO | Award / Grant | 4,134 | — | — | May 22, 2018 | |
| BIO-B | EVP and CFO | Option Exercise | 600 | $98.04 | $58,824 | Dec 14, 2017 |
| BIO-B | EVP and CFO | Tax Withholding | 76 | $218.04 | $16,571 | Sep 12, 2017 |
| BIO-B | EVP and CFO | Tax Withholding | 249 | $218.86 | $54,496 | Sep 11, 2017 |
| BIO-B | EVP and CFO | Option Exercise | 500 | — | — | Sep 7, 2017 |
| ONTO | Award / Grant | 3,453 | — | — | May 23, 2017 | |
| BIO-B | EVP and CFO | Tax Withholding | 76 | $164.74 | $12,520 | Nov 4, 2016 |
| BIO-B | EVP and CFO | Tax Withholding | 151 | $157.71 | $23,814 | Sep 12, 2016 |
| ONTO | Award / Grant | 6,493 | — | — | May 24, 2016 | |
| BIO-B | EVP and CFO | Option Exercise | 400 | $84.57 | $33,828 | Mar 14, 2016 |
| BIO-B | EVP and CFO | Option Exercise | 200 | — | — | Nov 4, 2015 |
| BIO-B | EVP and CFO | Option Exercise | 400 | — | — | Sep 12, 2015 |
| BIO-B | EVP and CFO | Option Exercise | 200 | — | — | Sep 9, 2015 |
| ONTO | Award / Grant | 6,223 | — | — | May 19, 2015 | |
| BIO-B | EVP and CFO | Option Exercise | 2,400 | $84.57 | $202,968 | Mar 12, 2015 |
| BIO-B | EVP and CFO | Sale | 1,326 | $115.85 | $153,617 | Nov 20, 2014 |
| BIO-B | EVP and CFO | Option Exercise | 3,000 | $74.27 | $222,810 | Nov 12, 2014 |
| BIO-B | EVP and CFO | Option Exercise | 200 | — | — | Nov 4, 2014 |
| BIO-B | EVP and CFO | Tax Withholding | 75 | $117.81 | $8,836 | Sep 12, 2014 |
| BIO-B | EVP and CFO | Option Exercise | 160 | — | — | Sep 11, 2014 |
| BIO-B | EVP and CFO | Option Exercise | 200 | — | — | Sep 8, 2014 |
| BIO-B | EVP and CFO | Tax Withholding | 75 | $121.96 | $9,147 | Jun 10, 2014 |
| ONTO | Award / Grant | 6,165 | — | — | May 20, 2014 | |
| BIO-B | Executive Vice President, CFO | Option Exercise | 200 | — | — | Nov 4, 2013 |
| BIO-B | EVP and CFO | Option Exercise | 200 | — | — | Sep 12, 2013 |
| BIO-B | Executive Vice President, CFO | Option Exercise | 200 | — | — | Sep 8, 2013 |